Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dyadic International
(NQ:
DYAI
)
1.640
-0.060 (-3.53%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dyadic International
< Previous
1
2
3
Next >
Earnings Scheduled For March 28, 2024
March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
Via
Benzinga
Dyadic International's Earnings: A Preview
March 27, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 11, 2024
Via
Benzinga
Recap: Dyadic International Q3 Earnings
November 08, 2023
Via
Benzinga
Dyadic International Earnings Perspective: Return On Capital Employed
March 30, 2023
Via
Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Exploring Dyadic International's Earnings Expectations
November 11, 2024
Via
Benzinga
DYAI Stock Earnings: Dyadic International Misses EPS, Misses Revenue for Q2 2024
August 13, 2024
DYAI stock results show that Dyadic International missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
DYAI Stock Earnings: Dyadic International Reported Results for Q1 2024
May 14, 2024
Dyadic International just reported results for the first quarter of 2024.
Via
InvestorPlace
DYAI Stock Earnings: Dyadic International Misses EPS, Misses Revenue for Q4 2023
March 28, 2024
DYAI stock results show that Dyadic International missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Recap: Dyadic International Q4 Earnings
March 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 19, 2024
Via
Benzinga
Earnings Outlook For Dyadic International
March 28, 2023
Via
Benzinga
Recap: Dyadic International Q1 Earnings
May 12, 2022
Dyadic International (NASDAQ:DYAI) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
India Funds Affordable COVID-19 Vaccine Candidate Using Dyadic's Platform
April 13, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 05, 2023
Via
Benzinga
Why Phibro Shares Are Trading Higher Today?
February 10, 2022
Phibro Animal Health Corp (NASDAQ: PAHC) and Dyadic International Inc (NASDAQ: DYAI) have entered into an
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 10, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 05, 2022
During Monday's session, 49 companies made new 52-week lows.
Via
Benzinga
Dyadic International: Q2 Earnings Insights
August 10, 2022
Dyadic International (NASDAQ:DYAI) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Preview: Dyadic International
August 09, 2022
Dyadic International (NASDAQ:DYAI) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.
Via
Benzinga
Dyadic International Earnings Perspective: Return On Capital Employed
March 30, 2022
Dyadic International (NASDAQ:DYAI) brought in sales totaling $313.29 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 145.67%, resulting in a loss of $4.21...
Via
Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
March 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
A Preview Of Dyadic International's Earnings
March 28, 2022
Dyadic International (NASDAQ:DYAI) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Dyadic...
Via
Benzinga
This Vaccine Stock Is Now On Janssen Pharmaceuticals, J&J, The White House's Radar
January 04, 2022
Dyadic International shares were up over 6% on January 3rd. Shares are up over 35% in the last month.
Via
Talk Markets
Earnings Scheduled For March 29, 2022
March 29, 2022
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.
Via
Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.